Article Details

On March, 20 BioSyent Inc. (RX) Analysts See $0.11 EPS

Retrieved on: 2019-02-18 12:31:58

Tags for this article:

Click the tags to see associated articles and topics

On March, 20 BioSyent Inc. (RX) Analysts See $0.11 EPS. View article details on HISWAI:

Excerpt

<div>BioSyent Inc. (CVE:RX) is anticipated to report earnings on March, 20., ... Inc (TSE:ACB) CCO Cam Battley on Spin-out and <b>Canopy Growth Corp</b> ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up